FDA rejects UniQure's AMT-130 data, sending shares tumbling as the company scrambles to find a path to approval.
California Governor Newsom's pivotal Prop 50 victory boosts his national profile, but faces criticism over misleading claims and environmental concerns.
Canadian investment regulator resumes trading oversight to ensure market integrity
FDA rejects UniQure's AMT-130 data, sending shares tumbling as the company scrambles to find a path to approval.
California Governor Newsom's pivotal Prop 50 victory boosts his national profile, but faces criticism over misleading claims and environmental concerns.
Canadian investment regulator resumes trading oversight to ensure market integrity